Bioharvest Sciences (BHST) Revenue (2023 - 2025)

Bioharvest Sciences' Revenue history runs 3 years deep, the most recent figure standing at $9.1 million for Q4 2025.

• On a quarterly basis, Revenue rose 24.57% year-over-year to $9.1 million in Q4 2025; TTM through Dec 2025 was $34.5 million, a 37.0% increase from a year earlier, with the FY2025 full-year figure at $34.5 million, up 37.0% from the prior year.
• Revenue held at $9.1 million in Q4 2025 per BHST's latest filing, from $9.1 million in the prior quarter.
• Across five years, Revenue topped out at $9.1 million in Q3 2025 and bottomed at $2.8 million in Q2 2023.
• The 3-year median for Revenue is $6.5 million (2024), against an average of $6.4 million.
• Across the five-year window, Revenue soared 119.16% in 2024 and rose 24.57% in 2025, its largest moves.
• Year by year, Revenue stood at $4.5 million in 2023, then soared by 61.02% to $7.3 million in 2024, then climbed by 24.57% to $9.1 million in 2025.
• Per Business Quant, the three latest BHST Revenue figures stand at $9.1 million (Q4 2025), $9.1 million (Q3 2025), and $8.5 million (Q2 2025).